Clinical Trials in China / NCT06450067
Recruiting
Observational
Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia
NCT06450067 · tracked via the Priya Life Science China tracker
Condition(s) studied
B-cell Acute Lymphoblastic Leukemia
Study summary
This clinical trial is a non-interventional, observational, multicenter, post-marketing real-world study to evaluate the efficacy and safety of Inaticabtagene Autoleucel Injection in Chinese adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia.
Eligibility
Inclusion Criteria:
1. Age ≥ 18 years;
2. Diagnosed with relapsed or refractory B-cell acute lymphoblastic leukemia;
3. Patients deemed eligible for receiving commercial Inaticabtagene Autoleucel injection treatment as determined by the investigator;
4. Patients voluntarily participate in this study and sign an informed consent form. For patients lacking full legal capacity, informed consent must be obtained from their legal guardian
Exclusion Criteria:
None
Primary outcome measure(s)
- overall survival — 2 years
OS is defined as the time from the start date of Inaticabtagene Autoleucel Injection infusion to the date of death due to any cause.
Trial sites (10)
| Facility | City | Region | Status |
|---|---|---|---|
| Peking University People's Hospital | Beijing | Beijing Municipality | Recruiting |
| Peking University Third Hospital | Beijing | Beijing Municipality | Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou | Guangdong | Recruiting |
| Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University | Zhengzhou | Henan | Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | Hubei | Recruiting |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou | Jiangsu | Recruiting |
| Qilu Hospital of Shandong university | Jinan | Shandong | Recruiting |
| Tongji Hospital of Tongji University | Shanghai | Shanghai Municipality | Recruiting |
| West China School of Medicine/West China Hospital of Sichuan University | Chengdu | Sichuan | Recruiting |
| Institute of Hematology & Blood Diseases Hospital | Tianjin | Tianjin Municipality | Recruiting |
More Juventas Cell Therapy Ltd. trials in China
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06450067 on ClinicalTrials.gov ↗ ← All trials in China